Doxepin is a tricyclic antidepressant that works by blocking the reabsorption of two key brain chemicals, serotonin and norepinephrine, while also powerfully blocking histamine receptors. What makes doxepin unusual is that its mechanism shifts depending on the dose: at higher doses (75 to 300 mg), it acts primarily as an antidepressant and anti-anxiety medication, while at very low doses (3 to 6 mg), it works almost exclusively as a histamine blocker to promote sleep.
Serotonin, Norepinephrine, and Mood
At antidepressant doses, doxepin prevents nerve cells from reabsorbing serotonin and norepinephrine after they’ve been released. These two chemicals carry signals between brain cells that regulate mood, motivation, and emotional resilience. When doxepin blocks their reuptake, more of each chemical stays active in the gaps between neurons, strengthening those mood-related signals over time.
This reuptake-blocking effect is the same basic principle behind many antidepressants, but tricyclics like doxepin are less selective than newer drugs. They don’t just target serotonin and norepinephrine pathways. They also bind to histamine, acetylcholine, and other receptors throughout the body. That broader activity is why doxepin treats several conditions but also why it produces a wider range of side effects than more modern antidepressants.
Histamine Blocking and Sleep
Doxepin has what researchers describe as “subnanomolar affinity” for the histamine H1 receptor, meaning it binds to this receptor with extraordinary potency, far more tightly than it binds to serotonin or norepinephrine transporters. Histamine is one of the brain’s primary wakefulness signals. When doxepin blocks H1 receptors, that alerting signal is dampened, and sleep becomes easier to maintain.
At low doses of 3 to 6 mg, doxepin’s concentration in the blood is high enough to occupy histamine receptors but too low to meaningfully affect serotonin, norepinephrine, or acetylcholine pathways. This selective targeting is the reason ultra-low-dose doxepin was approved specifically for insomnia. It helps people stay asleep through the night without the anticholinergic side effects (dry mouth, constipation, blurred vision) that come with higher doses. At these low doses, the side effect profile is comparable to a placebo.
How Dose Changes What It Does
The dose of doxepin essentially determines which condition it treats, because different receptors get activated at different blood concentrations:
- 3 to 6 mg (insomnia): Blocks histamine H1 receptors almost exclusively. Taken within 30 minutes of bedtime, typically for less than 4 to 8 weeks.
- 25 to 300 mg (depression and anxiety): Blocks reuptake of serotonin and norepinephrine while also affecting histamine, acetylcholine, and other receptors. The starting dose is usually 25 to 75 mg at bedtime, increased by 25 to 50 mg every third day until reaching the therapeutic range of 100 to 300 mg daily.
This dose-dependent selectivity is relatively unusual among psychiatric medications and is the key to understanding why one drug appears on prescriptions for such different problems.
Topical Doxepin for Itching
Doxepin also comes in a cream form used for itching caused by conditions like eczema. Applied to the skin, it blocks histamine locally in the tissue, reducing the itch signal before it reaches the brain. Some doxepin does absorb through the skin into the bloodstream, which can cause drowsiness, but the primary action is at the site of application.
Anticholinergic Effects
At antidepressant doses, doxepin blocks acetylcholine receptors throughout the body. Acetylcholine controls functions like saliva production, bladder contraction, bowel movement, and the muscles that adjust pupil size. Blocking it produces the classic tricyclic side effects: dry mouth, constipation, blurred vision, and difficulty urinating.
The pupil dilation caused by this anticholinergic activity is the specific reason doxepin is contraindicated for people with narrow-angle glaucoma. When the pupil widens, it can physically block the drainage angle inside the eye, causing a sudden dangerous spike in eye pressure. Similarly, reduced bladder muscle activity is why it’s avoided in people with urinary retention problems.
Doxepin also blocks a type of receptor in blood vessels that helps maintain blood pressure when you stand up. This can cause orthostatic hypotension, a drop in blood pressure that leads to dizziness or lightheadedness upon standing. The 2023 American Geriatrics Society Beers Criteria strongly recommends avoiding doxepin above 6 mg per day in older adults for this reason, citing its highly anticholinergic and sedating properties along with the risk of falls from blood pressure drops. Low-dose doxepin (6 mg or under) is considered safe in this population.
How the Body Processes Doxepin
After you take a dose, doxepin is absorbed rapidly, reaching peak blood levels in about 30 minutes to 2 hours. Your liver then converts it into an active metabolite called nordoxepin, which also blocks histamine and neurotransmitter reuptake. Nordoxepin reaches its own peak concentration within about 30 minutes to 2 hours as well. Both the original drug and nordoxepin contribute to the therapeutic effect, which is one reason the sedating effects of a bedtime dose can persist into the following morning, especially at higher doses.
Because doxepin is processed by specific liver enzymes, medications that slow those enzymes down can increase doxepin levels in the blood, intensifying both its effects and side effects. This includes certain antifungals, some antidepressants, and other drugs that compete for the same metabolic pathways. The combination of doxepin with MAO inhibitors (an older class of antidepressant) is particularly dangerous and requires a washout period between stopping one and starting the other.